Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Blueprint Genetics Finland | 8 | 41 |
|
Comprehensive Metabolism Panel Blueprint Genetics Finland | 14 | 434 |
|
Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University United States | 4 | 92 |
|
Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University United States | 2 | 60 |
|
Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University United States | 5 | 98 |
|
Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University United States | 4 | 77 |
|
Epilepsy Comprehensive NGS Panel Fulgent Genetics United States | 729 | 398 |
|
CeGaT GmbH Germany | 1 | 1 |
|
CeGaT GmbH Germany | 3 | 4 |
|
CeGaT GmbH Germany | 3 | 37 |
|
Fulgent Genetics United States | 1 | 1 |
|
Hyperphenylalaninemia, BH4-deficient, C (QDPR) Amsterdam UMC, Location AMC Laboratory Genetic Metabolic Diseases, LGMD Netherlands | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Fulgent Genetics United States | 1103 | 676 |
|
Fulgent Genetics United States | 186 | 106 |
|
BH4-Deficient Hyperphenylalaninemia C Department of Clinical Genetics Copenhagen University Hospital, Rigshospitalet Denmark | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.